| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 34.308 | 16.008 | 14.181 | 26.735 | 19.560 | 24.268 | 55.978 | 31.656 | 57.365 | 65.694 |
| Total Income - EUR | 34.308 | 16.008 | 14.181 | 26.736 | 19.828 | 24.270 | 55.980 | 31.659 | 57.371 | 65.706 |
| Total Expenses - EUR | 6.420 | 27.382 | 5.512 | 19.163 | 12.280 | 16.527 | 26.052 | 19.266 | 36.757 | 54.038 |
| Gross Profit/Loss - EUR | 27.889 | -11.373 | 8.669 | 7.573 | 7.548 | 7.742 | 29.928 | 12.393 | 20.614 | 11.668 |
| Net Profit/Loss - EUR | 26.859 | -11.854 | 8.243 | 6.782 | 6.953 | 7.045 | 28.248 | 11.443 | 16.792 | 8.926 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Aliski-Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 1.432 | 1.644 | 1.045 | 1.062 | 482 | 180 | 578 | 1.817 | 38.817 | 29.222 |
| Current Assets | 51.809 | 37.466 | 45.545 | 54.136 | 61.493 | 71.048 | 56.626 | 55.475 | 34.789 | 40.174 |
| Inventories | 1.000 | 0 | 0 | 0 | 0 | 0 | -1 | 4.056 | 1.398 | 0 |
| Receivables | 7.493 | 9.020 | 6.765 | 12.002 | 8.187 | 12.297 | 37.572 | 14.598 | 12.291 | 18.298 |
| Cash | 43.317 | 28.446 | 38.780 | 42.133 | 53.306 | 58.750 | 19.055 | 36.821 | 21.100 | 21.876 |
| Shareholders Funds | 46.694 | 34.364 | 42.026 | 48.037 | 54.060 | 60.080 | 35.185 | 46.738 | 63.389 | 53.387 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 6.547 | 4.745 | 4.564 | 7.160 | 7.915 | 11.148 | 22.019 | 10.553 | 10.217 | 16.008 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4619
|
|||||||||
Comments - Aliski-Med Srl